依达拉奉联合血栓通治疗急性脑梗死的临床观察

Efficacy of Edaravone Xueshuantong Treatment in Patients With Acute Cerebral Infarction

目的分析依达拉奉联合血栓通治疗急性脑梗死的临床疗效。方法将95例患者分为两组,治疗组52例在对照组43例血栓通治疗基础上联合依达拉奉。结果治疗组总有效率96.2%,高于对照组的79.1%,血清CRP低于对照组,血液流变学较对照组改善,P<0.05,无不良反应。结论依达拉奉联合血栓通治疗急性脑梗死取得让人满意的效果。

ObjectiveTo analyze the clinical efficacy of edaravone and xueshuantong treatment in acute cerebral infarction.Methods Ninety-five patients were divided into two groups,52 patients in study group were xueshuantong treatment plus edaravone and 43 patients in control group were given xueshuantong treatment. Results The total efficiency in study group（96.2%）was higher than control group （79.1%）,serum CRP was lower than the control group,improve blood rheology was better than the control group,P〈 0.05,no adverse reactions.Conclusion Edaravone treatment of acute cerebral infarction xueshuantong achieved satisfactory results.